Publications

Detailed Information

Relationships between 24-Hour Blood Pressures, Subcortical Ischemic Lesions, and Cognitive Impairment

DC Field Value Language
dc.contributor.authorKim, Jung Eun-
dc.contributor.authorShin, Ji Soo-
dc.contributor.authorJeong, Jee Hyang-
dc.contributor.authorChoi, Kyong Gyu-
dc.contributor.authorKim, SangYun-
dc.contributor.authorPark, Kee Duk-
dc.date.accessioned2012-06-25T05:11:29Z-
dc.date.available2012-06-25T05:11:29Z-
dc.date.issued2009-09-
dc.identifier.citationJOURNAL OF CLINICAL NEUROLOGY; Vol.5 3; 139-145ko_KR
dc.identifier.issn1738-6586-
dc.identifier.urihttps://hdl.handle.net/10371/77383-
dc.description.abstractBackground and Purpose The most important treatment for subcortical vascular dementia (SVaD) is controlling the blood pressure (BP). However, the few studies that have investigated the relationships between diurnal BP rhythm and subcortical ischemic vascular cognitive impairment have produced inconclusive results. In the study presented here, the 24-hour BP values of three groups of subjects-patients with subcortical vascular mild cognitive impairment (SvMCI), patients with SVaD, and normal controls-were compared using working criteria and 24-hour ambulatory BP (ABP) monitoring. Methods The subjects (42 patients with SVaD, 37 patients with SvMCI, and 30 controls) were selected according to the Study`s inclusion/exclusion criteria. All subjects underwent brain magnetic resonance (MR) imaging and MR angiography, detailed neuropsychological testing, and 24-hour ABP monitoring. Results The prevalence of nondippers differed markedly between the control group and both the SVaD and SvMCI groups. Loss of nocturnal dipping was significantly associated with SVaD [odds ratio (OR), 4.827; 95% confidence interval (CI), 1.07-12.05]. Conclusions It was found that SVaD is associated with loss of nocturnal BP dipping combined with increased pulse pressure and systolic BP (SBP) variability. Correction of these factors could therefore be important in the prevention of SVaD, independent of measures used to reduce BP. J Clin Neurol 2009;5:139-145ko_KR
dc.language.isoenko_KR
dc.publisherKOREAN NEUROLOGICAL ASSOCko_KR
dc.subject24-hour blood pressure valuesko_KR
dc.subjectsubcortical vascular mild cognitive impairmentko_KR
dc.subjectsubcortical vascular dementiako_KR
dc.titleRelationships between 24-Hour Blood Pressures, Subcortical Ischemic Lesions, and Cognitive Impairmentko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor김정은-
dc.contributor.AlternativeAuthor신지수-
dc.contributor.AlternativeAuthor정지형-
dc.contributor.AlternativeAuthor최경규-
dc.contributor.AlternativeAuthor박기덕-
dc.contributor.AlternativeAuthor김상윤-
dc.identifier.doi10.3988/jcn.2009.5.3.139-
dc.citation.journaltitleJOURNAL OF CLINICAL NEUROLOGY-
dc.description.citedreferenceOhmine T, 2008, HYPERTENS RES, V31, P75-
dc.description.citedreferencevan Boxtel MPJ, 2006, J HUM HYPERTENS, V20, P5, DOI 10.1038/sj.jhh.1001934-
dc.description.citedreferencevan der Flier WM, 2005, STROKE, V36, P2116-
dc.description.citedreferenceBirns J, 2005, STROKE, V36, P1308, DOI 10.1161/01.STR.0000165901.38039.5f-
dc.description.citedreferenceYamamoto Y, 2005, CEREBROVASC DIS, V19, P302, DOI 10.1159/000084498-
dc.description.citedreferenceBOWLER JV, 2005, J NEUROL NEUROSUR S5, V76, P35-
dc.description.citedreferenceKU HM, 2004, J KOREAN NEUROPSYCHI, V43, P189-
dc.description.citedreferenceO`Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/01.hjh.0000059016.82022.ca-
dc.description.citedreferenceKANG Y, 2003, INCHEON HUMAN BRAIN-
dc.description.citedreferenceOhkubo T, 2002, J HYPERTENS, V20, P2183-
dc.description.citedreferencede Leeuw FE, 2002, BRAIN, V125, P765-
dc.description.citedreferenceO`Brien JT, 2002, ANN NY ACAD SCI, V977, P436-
dc.description.citedreferenceKario K, 2001, HYPERTENSION, V38, P852-
dc.description.citedreferenceWahlund LO, 2001, STROKE, V32, P1318-
dc.description.citedreferenceDufouil C, 2001, NEUROLOGY, V56, P921-
dc.description.citedreferencePuisieux F, 2001, EUR NEUROL, V46, P115-
dc.description.citedreferenceStaessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539-
dc.description.citedreferenceSwan GE, 1998, NEUROLOGY, V51, P986-
dc.description.citedreferenceBlacher J, 1998, HYPERTENSION, V32, P570-
dc.description.citedreferenceCummings JL, 1998, J PSYCHOSOM RES, V44, P627-
dc.description.citedreferenceKilander L, 1998, HYPERTENSION, V31, P780-
dc.description.citedreferenceGuo ZC, 1997, AM J EPIDEMIOL, V145, P1106-
dc.description.citedreferenceLiao DP, 1996, STROKE, V27, P2262-
dc.description.citedreferenceLAUNER LJ, 1995, JAMA-J AM MED ASSOC, V274, P1846-
dc.description.citedreferenceYAMAMOTO Y, 1995, STROKE, V26, P829-
dc.description.citedreferenceVERDECCHIA P, 1994, HYPERTENSION, V24, P793-
dc.description.citedreferenceKUUSISTO J, 1993, HYPERTENSION, V22, P771-
dc.description.citedreferenceSHIMADA K, 1992, J HYPERTENS, V10, P875-
dc.description.citedreferenceSCHERR PA, 1991, AM J EPIDEMIOL, V134, P1303-
dc.description.citedreferenceTOHGI H, 1991, STROKE, V22, P603-
dc.description.citedreferenceOBRIEN E, 1988, LANCET, V2, P397-
dc.description.citedreferencePARATI G, 1987, J HYPERTENS, V5, P93-
dc.description.citedreferenceHACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632-
dc.description.tc1-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share